InvestorsHub Logo
Followers 38
Posts 324
Boards Moderated 0
Alias Born 10/09/2013

Re: None

Tuesday, 01/02/2018 8:24:53 AM

Tuesday, January 02, 2018 8:24:53 AM

Post# of 34605
Once again 10/11 million shares offering is nothing, 20 million OS at that point. Who even says at this point that all warrants or shares will be issued?
If they do the offering at 3 or 4 dollars, they end up with 30/40 million enough to fund all trials until commercialization.

The float is way to small right now, if the Phase 1 data is good, or the initial Phase 2 then they will most definitely need the extra shares.

If you are any kind of investor, you know the need for large sums of cash in the Bio Tech world, and on any given stock you know that 20 million shares OS is miniscule.

Anyone here that has any intelligence knows that to sell now, anyone who has held Tapimmune for years {much less 13/15 lol] knows that it would be ridiculous to sell at this point.

Tapimmune and it's management have done a great job to date, accomplished everything that they have needed to this point.

Cash is king in the market, and Houng, I believe will get a fair market price.

Do what is right for "YOU", don't be swayed by those with obvious, negative agenda's, that are only meant to further their needs.

Contrary to negative posts, Tapimmune is poised and ready to take off, with any kind of positive news.

BLU
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News